Overview

Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare standard treatment and fusion ontogenetic surgery (total mesometrial resection, laterally extended endopelvic resection, peritoneal mesometrial resection) for gynecologic cancer in order to evaluate treatment response, adverse effect and survival.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Cisplatin
Doxorubicin
Fluorouracil
Liposomal doxorubicin